Retatrutide Beats Ozempic on Weight and A1C in Late-Stage Diabetes Trial
Lilly reports retatrutide cut 20.9% of body weight at 80 weeks versus 9.4% for Ozempic and lowered A1C more, a company-reported result with full data still pending.
Read article →